daunorubicin has been researched along with Invasiveness, Neoplasm in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Cai, FY; Fu, M; Gong, XQ; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Tang, W; Yao, XM | 1 |
Liu, J; Wang, Y; Yang, L; Yao, Q; Zhang, L | 1 |
Chao, JP; Cheng, L; Ju, RJ; Li, CQ; Li, XT; Liu, S; Peng, XM; Song, XL; Wang, T | 1 |
Ishikawa, M; Kato, R; Miyagishima, T; Muranaka, T; Oda, H; Sawada, K; Sogabe, S; Takahashi, K; Takasaka, T; Umemura, M | 1 |
Dang, NH; Ghani, FI; Iwata, S; Morimoto, C; Naito, M; Yamazaki, H | 1 |
Hiraishi, Y; Kuribayashi, T; Oshima, Y; Shitara, T; Suetake, N | 1 |
Deguchi, M; Kitazawa, S; Maeda, S; Mochizuki, M; Ohara, N; Ohta, T; Takeuchi, S | 1 |
1 review(s) available for daunorubicin and Invasiveness, Neoplasm
Article | Year |
---|---|
Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Daunorubicin; Drug Delivery Systems; Emodin; Female; Humans; Liposomes; Mice; Neoplasm Invasiveness; Particle Size | 2020 |
6 other study(ies) available for daunorubicin and Invasiveness, Neoplasm
Article | Year |
---|---|
LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Cycle; Cell Movement; Cell Proliferation; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Leukemia; MicroRNAs; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; RNA, Long Noncoding; Signal Transduction; U937 Cells | 2021 |
Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer.
Topics: Ammonium Sulfate; Animals; Artemisinins; Biological Transport; Breast Neoplasms; Cell Movement; Daunorubicin; Humans; Lipid Bilayers; Liposomes; MCF-7 Cells; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Octreotide; Polyethylene Glycols; Wound Healing; Xenograft Model Antitumor Assays | 2018 |
[Case report; myeloid sarcoma with systemic lymphadenopathy, skin and gastrointestinal infiltration].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Gastrointestinal Neoplasms; Humans; Lymphatic Diseases; Male; Neoplasm Invasiveness; Sarcoma, Myeloid; Skin Neoplasms | 2014 |
Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; CD24 Antigen; Cell Division; Cell Line, Tumor; Daunorubicin; Dipeptidyl Peptidase 4; Drug Resistance, Neoplasm; ErbB Receptors; Etoposide; Gene Expression; Gene Knockdown Techniques; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Proteins; Mesothelioma; Neoplasm Invasiveness; Neoplastic Stem Cells; RNA Interference; RNA, Small Interfering | 2012 |
[Results of modified LSA2L2 therapy in children with non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma; Male; Methotrexate; Neoplasm Invasiveness; Prednisone; Vincristine | 1984 |
[A case of acute myeloblastic leukemia invaded uterine cervix-diagnosed by changes in peripheral blood after G-CSF administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Daunorubicin; Diagnosis, Differential; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Mercaptopurine; Middle Aged; Neoplasm Invasiveness; Prednisolone; Prednisone; Recombinant Proteins; Uterine Cervical Neoplasms; Vincristine | 1993 |